Professional
Added to YB: 2025-12-18
Pitch date: 2025-10-11
MEDP [neutral]
Medpace Holdings, Inc.
-2.3%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$507.69
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Wasatch Small Cap Growth Fund Portfolio Holding: Medpace Holdings, Inc.
MEDP (holding update): Top fund contributor, CRO providing drug dev/clinical trial services to biotech/pharma. Strong rev & earnings growth, raised FY guidance. Results impressive despite biotech funding slowdown. Shares jumped on results.
Read full article (1 min)